NCT01642030 - Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Opioid DependencePainAddiction

Interventions

DRUG

Placebo

Intravenous injection of approximately 5 mL administered via slow push over 5 minutes. Given 4 injections during the session with each injection separated by 1.5 hours.

DRUG

Hydromorphone

Intravenous injection of approximately 5 mL administered via slow push over 5 minutes. Given 4 injections during the session with each injection separated by 1.5 hours.

DRUG

Buprenorphine

Intravenous injection of approximately 5 mL administered via slow push over 5 minutes. Given 4 injections during the session with each injection separated by 1.5 hours.

Trial Locations (1)

21224

Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER